Page last updated: 2024-10-22

alendronate and Leukocyte Disorders

alendronate has been researched along with Leukocyte Disorders in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Leukocyte Disorders: Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.

Research Excerpts

ExcerptRelevanceReference
"Atorvastatin (ATV) has bone anabolic properties, and alendronate (ALD) is an important antiresorptive drug."1.40Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats. ( Alencar, NM; Benevides, NM; Goes, P; Lima, V; Melo, IM; Ribeiro, RA; Silva, LM, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goes, P1
Melo, IM1
Silva, LM1
Benevides, NM1
Alencar, NM1
Ribeiro, RA1
Lima, V1

Other Studies

1 other study available for alendronate and Leukocyte Disorders

ArticleYear
Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats.
    Journal of periodontal research, 2014, Volume: 49, Issue:1

    Topics: Acid Phosphatase; Alanine Transaminase; Alendronate; Alkaline Phosphatase; Alveolar Bone Loss; Anima

2014